ArticleCancers2022

Use of Venetoclax in Patients with Relapsed or Refractory Acute Myeloid Leukemia: The PETHEMA Registry Experience.

Jorge Labrador et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.